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Abstract In contrast to the general model of cytokine-induced
JAK/STAT signaling, tyrosine phosphorylation of the IL-5R L
chain seems to be dispensable for STAT activation in cells
overexpressing exogenous STAT proteins. In this study we
expressed IL-5 receptor mutants in 293 cells and studied IL-5-
induced endogenous STAT-dependent transcription. Our results
indicate that: (a) tyrosine phosphorylation of the IL-5R L chain
is required for endogenous STAT5 activation, (b) multiple
tyrosine residues are phosphorylated upon IL-5 stimulation,
including Tyr
577
, Tyr
612
, Tyr
695
, and Tyr
750
, and (c) Tyr
612
,
Tyr
695
, and Tyr
750
are all capable of inducing activation of
STAT5, demonstrating a high level of functional redundancy
within the IL-5R L chain.
z 1997 Federation of European Biochemical Societies.
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1. Introduction
Cytokines such as interleukin-5 (IL-5), IL-3 and granulo-
cyte macrophage colony-stimulating factor (GM-CSF) play a
crucial role in the proliferation, di¡erentiation, and activation
of blood cells and their precursors [1,2]. IL-5 is essential for
eosinophil proliferation and di¡erentiation [3] and is the key
regulator of survival, migration, and activation of mature eo-
sinophils [4^6]. The IL-5 receptor is composed of a speci¢c IL-
5R K chain which is only expressed on eosinophils and baso-
phils [7] and a common Lc subunit that is shared with the
receptors for IL-3 and GM-CSF [8]. Both the K and Lc chains
are necessary for signal transduction by IL-5 [9^11].
IL-5 induces rapid and reversible tyrosine phosphorylation
of cellular proteins in both hematopoietic cells and ¢broblasts
[6,9]. Tyrosine phosphorylated proteins include the Lc subunit
itself and proteins that belong to the ras-MAPK pathway and
the JAK-STAT pathway [9,11^13]. Recent studies have shown
that several tyrosine kinases of the Src-family, including
p59
fyn
[14] and p53/56
lyn
[15], and others, such as Tec [16]
and p93
fes
[17], are activated via the Lc subunit in di¡erent
cellular systems.
The Janus tyrosine kinase JAK2 is activated in response to
IL-3, IL-5, and GM-CSF and speci¢cally associates with the
membrane-proximal region of the L chain [12,18]. JAK2 then
activates the transcription factors STAT1, STAT3 and
STAT5, depending on the cell type studied [11,13,19]. A num-
ber of studies have suggested that activated JAKs can phos-
phorylate tyrosine residues within the cytokine receptor, pro-
viding speci¢c binding sites for the SH2 domain of the STAT
transcription factors. Support for this model has been ob-
tained from di¡erent receptor systems, including the IFN-Q
[20], IL-2 [21], IL-4 [22], IL-6 [23], IL-9 [24], erythropoietin
(EPO) [25,26], and growth hormone (GH) receptors [27]. By
contrast, we and others have shown that deletion mutants of
the common L that lack tyrosine residues, can still activate
STAT1 and STAT3 (when overexpressed in COS cells) [11]
and STAT5 (when overexpressed in BA/F3 cells) [13], suggest-
ing that tyrosine phosphorylation is dispensable for STAT
activation by IL-5.
In this paper we report that multiple tyrosine residues in the
IL-5RL, including Tyr
577
, Tyr
612
, Tyr
695
, and Tyr
750
, can be
phosphorylated upon IL-5 signaling. Tyrosine phosphoryla-
tion of either Tyr
612
, Tyr
695
, or Tyr
750
is necessary and su¤-
cient for maximal endogenous STAT activation, showing the
existence of a high level of functional redundancy within the
IL-5RL.
2. Materials and methods
2.1. Cell culture, reagents, and antibodies
293, Rat-1, and 3T3 cells were cultured in Dulbecco's modi¢ed
Eagle's medium (Gibco) supplemented with 8% heat-inactivated fetal
calf serum (FCS). HL-60 cells were maintained in RPMI 1640 supple-
mented with 8% Hyclone serum (Gibco). Human IL-5 (hIL-5) was a
kind gift of Dr. D. Fattah (Glaxo Wellcome Group Research, Steven-
age, UK). Polyclonal rabbit antibodies against the IL-5R L chain were
produced by immunization of rabbits with the histidine-tagged extra-
cellular part of the IL-5R L chain; anti-phosphotyrosine monoclonal
antibody (4G10) was obtained from UBI (Lake Placid, NY); mono-
clonal antibody against STAT1 (G16920) was obtained from Trans-
duction Laboratories (Lexington, KY); antibodies against STAT3 (K-
15), STAT5a (L-20) and STAT5b (C-17) were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA).
2.2. Synthetic oligonucleotides and plasmid construction
The following oligonucleotides were used in this study (only the
upper strands are shown): the human ICAM-1 IRE (5P-AGCT-
TAGTTTCCGGGAAAGCAC-3P), the c-fos SIEm67 (5P-AGCTT-
CATTTCCCGTAAATCA-3P), the FcQRI (5P-AGCTTGAGATGTA
TTTCCCAGAAAAGA-3P) and the L-casein (5P-AGCTTAGATTTC-
TAGGAATTCAA ATCA-3P). These oligonucleotides were multimer-
ized and cloned in the pBlCAT2 reporter. pSV-lacZ, expression vec-
tors for the IL-5R K and L chains and deletion constructs of the Lc
were described previously [11,28]. Site-directed mutagenesis was per-
formed as described by Kunkel [29].
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2.3. Transient transfection, immunoprecipitation, Western blot analysis
and gel retardation assay
Transient transfection experiments and CAT assays were performed
as described previously [11,28]. Immunoprecipitation and Western
blotting of STAT proteins from transfected 293 cells (20 cm
2
dishes,
Nunc) or HL-60 cells were performed as described previously [11].
Nuclear extracts were prepared from unstimulated and IL-5-stimu-
lated Rat-1 cells and 3T3 cells and assayed for STAT binding as
described previously [11].
3. Results
To determine the domains in the IL-5R L chain involved in
the activation of endogenous STAT proteins, several trun-
cated forms (Fig. 1A) were transfected together with the IL-
5 receptor K subunit and a reporter containing FcQRI STAT
binding sites in 293 cells. Fig. 1B shows that truncation of the
L chain down to amino acid 615 (L615) did not a¡ect the level
of IL-5 induced CAT activity. Deleting the next 4 amino acids
encompassing the tyrosine phosphorylation site YLSL (L611)
greatly reduced IL-5-induced CAT activity. A further reduc-
tion was observed using deletion mutant L456, which contains
only the ¢rst seven amino acids of the intracellular domain.
Similar results were obtained in Rat-1 and 3T3 cells (not
shown). This indicates that amino acids 611^615 and amino
acids 581^456 are important for IL-5-induced endogenous
STAT activation.
In parallel, we tested IL-5-induced tyrosine phosphorylation
of the Lc deletion constructs. In Fig. 1C it is shown that L881
(the full-length receptor), L763, L627, and L615 are heavily
phosphorylated after IL-5 stimulation. A clear drop in phos-
phorylation was observed in constructs lacking Tyr
612
, like
L581 and L611, suggesting that Tyr
612
is phosphorylated.
No tyrosine phosphorylation was observed in shorter con-
structs lacking Tyr
577
, like L568 and L456, indicating that
Tyr
577
was also phosphorylated. Interestingly, this tyrosine
residue is also phosphorylated in BA/F3 cells in response to
GM-CSF [30]. The di¡erences in the loading controls of Fig.
1C are partially caused by the fact that the longer mutants are
less well expressed compared to the shorter constructs.
To determine which STAT was activated in 293 cells, we
immunoprecipitated STAT1, STAT3, STAT5a and STAT5b
from IL-5-treated 293 cells and assayed the phosphorylation
on tyrosine residues. While STAT1, 3 and 5a were not acti-
vated by IL-5 (not shown), STAT5b was tyrosine phospho-
rylated in 293 cells after IL-5 stimulation (Fig. 1D). Similar
results were obtained in Rat-1 and 3T3 cells (not shown).
To assess whether Tyr
612
and Tyr
577
are important for
STAT5 induction, we mutated tyrosine 612 to phenylalanine
(612F) and tyrosine 577 to glycine (577G) in the L627 deletion
mutant (L627YY). The single mutations of Tyr
577
(L627GY)
or Tyr
612
(L627YF) result in a dramatic decrease of phospho-
rylation, while mutation of both residues completely inhibited
IL-5-induced phosphorylation (Fig. 2A). We next mutated
tyrosines 577 and 612 in the context of the full-length receptor
(L881GFYYYY). Interestingly, when stimulated with IL-5,
this mutant L chain was still phosphorylated (Fig. 2B). This
indicated that other tyrosines were phosphorylated. To iden-
tify these tyrosines, the same mutations were made in L826
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Fig. 1. IL-5-induced activation of STAT5 and tyrosine phosphorylation of IL-5R L-chain deletion mutants in 293 cells. (a) Structure of the
full-length IL-5R L-chain and deletion mutants used in this study. Intracellular tyrosine residues (Y) are indicated by numbers, box 1 and box
2 are indicated by shaded rectangles, the extracellular domains are partially indicated. (b) 293 cells were transfected with the IL-5RK chain (1
Wg) and truncated Lc receptors (1 Wg) together with a 4xGAStkCAT reporter construct (2 Wg). 24 h post-transfection, IL-5 (10
310
M) was
added for another 16 h. Fold induction represents CAT activity in IL-5-treated cells relative to untreated cells, and is the mean of three inde-
pendent experiments. (c) 293 cells expressing wild-type or mutant L chains were incubated without (3) or with 5U10
310
M hIL-5 (+) for 15
min at 37³C. Whole-cell lysates were immunoprecipitated with a polyclonal antibody against the L chain, and immunoprecipitates were analysed
using anti-pY (top panel) or anti-Lc (bottom panel) antibodies. Lc proteins appear as two bands, of which only the upper band is phosphoryl-
ated after IL-5 stimulation. The lower bands might represent incorrectly processed forms of Lc which are not expressed at the cell surface, and
can therefore not respond to IL-5. (d) 293 cells were transfected with the IL-5RK and L chain and incubated without (3) or with 5U10
310
M
hIL-5 (+) for 15 min at 37³C. HL-60 cells stimulated with GM-CSF served as a positive control. Whole-cell lysates were immunoprecipitated
with a STAT5b antibody. The immunoprecipitates were analyzed with anti-pY (top panel) or anti-STAT5b (bottom panel).
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(L826GFYYY-) and L763 (L763GFYY- -), which eliminated
Tyr
866
and Tyr
806
, respectively. Both these receptor mutants
are phosphorylated (Fig. 2B). L763GFYY- - contains only
two tyrosine residues: Tyr
695
and Tyr
750
. To discriminate be-
tween these, three mutants were constructed: L763GFTY- -
only containing Tyr
750
, L751GFYF- - only containing
Tyr
695
, and L763GFTA- - containing no tyrosine residue.
Phosphorylation studies with these constructs showed that
both Tyr
695
and Tyr
750
could be phosphorylated, albeit at
low levels (Fig. 2B and not shown). Taken together, tyrosine
residues 577, 612, 695, and 750 in the IL-5RL are phospho-
rylated upon IL-5 stimulation.
To determine whether tyrosine phosphorylation of the Lc
chain is involved in STAT5 activation, we tested the di¡erent
mutations in 293 cells. In the context of L627, only mutation
of Tyr
612
(L627YF) resulted in a clear drop in CAT activity
after IL-5 stimulation, while mutation of only Tyr
577
(L627GY) had no e¡ect (Fig. 3A). The double mutant
L627GF did not induce any increase CAT activity. Therefore,
although both tyrosines are phosphorylated after IL-5 stimu-
lation (Fig. 2A), only Tyr
612
plays a major role in STAT
activation in the context of L627. Surprisingly, mutation of
Tyr
612
and Tyr
577
in the context of L881, L826 and L763 did
not result in a decrease in IL-5-induced CAT activity (Fig.
3B). Moreover, mutants containing only Tyr
695
(763 GFYF)
or Tyr
750
(763 GFTY) were capable of inducing STAT activ-
ity (Fig. 3B). Importantly, L763GFTA- - was the only recep-
tor mutant in this panel that is not phosphorylated after IL-5
stimulation (Fig. 2B) and does not support IL-5-induced CAT
activity. Therefore, phosphorylation of either Tyr
612
, Tyr
695
or
Tyr
750
is both necessary and su¤cient for STAT activation by
IL-5.
4. Discussion
The major conclusion from our study is that tyrosine phos-
phorylation of the IL-5R L chain is essential for endogenous
STAT5 activation. This is in contrast with previous data
where tyrosine phosphorylation of the L chain was not im-
portant for STAT activation in COS and BA/F3 cells [11,13].
However, in these studies the STAT proteins were overex-
pressed, while we have studied activation of endogenous
STAT proteins. Interestingly, when STAT proteins are over-
expressed in 293 cells, receptor phosphorylation is dispensable
for IL-5-induced STAT activation (data not shown). An alter-
native mechanism for activation of overexpressed STAT pro-
teins can be the recruitment of STAT5 to activated JAK2 or
other cytoplasmic tyrosine kinases without binding to the re-
ceptor, resulting in tyrosine phosphorylation and activation of
STAT proteins.
Previous work has shown that Tyr
577
and Tyr
750
of the L
chain are phosphorylated in BA/F3 cells after GM-CSF stim-
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Fig. 3. Tyrosine redundancy in the L chain for STAT activation.
293 cells were transfected with 1 Wg IL-5R K chain and 1 Wg of the
mutant L receptors together with 2 Wg 4xGAStkCAT reporter con-
struct, after which IL-5-induced STAT activation was measured as
described for Fig. 1B. (a) Mutation of Tyr
577
(627GY), Tyr
612
(627YF) or both (627GF) in the L627 (627YY) context clearly
shows that Tyr
612
is important for STAT5 activation. (b) Mutation
of Tyr
577
and Tyr
612
(GF) in the L881, L826 and L763 deletion con-
structs and mutation of Tyr
577
, Tyr
612
and Tyr
695
(GFTY) or
Tyr
577
, Tyr
612
, Tyr
695
and Tyr
750
(GFTA) in the L763 (YYYY) con-
text shows that Tyr
612
, Tyr
695
and Tyr
750
are able to mediate
STAT5 activation.
Fig. 2. IL-5 induces phosphorylation of Tyr
577
, Tyr
612
, Tyr
695
and Tyr
750
of the Lc chain. 293 cells expressing wild-type or mutant L chains
were incubated without (3) or with 5U10
310
M hIL-5 (+) for 15 min at 37³C. L chain phosphorylation was assayed as described for Fig. 1C.
(a) Mutation of Tyr
577
(627GY), Tyr
612
(627YF) or both (627GF) in the L627 (627YY) context. As described for Fig. 1C, L627 appears as two
bands, of which only the upper band (indicated by an arrowhead) is phosphorylated after IL-5 stimulation. (b) Mutation of Tyr
577
and Tyr
612
(GF) in the L881, L826 and L763 deletion constructs, and mutation of Tyr
577
, Tyr
612
and Tyr
695
(GFTY) or Tyr
577
, Tyr
612
, Tyr
695
and Tyr
750
(GFTA) in the L763 context. L881, L826, and L763 run as a double band (indicated by an arrowhead) in between two unspeci¢c bands. These
unspeci¢c bands are more obvious in the left panel, since this panel was exposed longer than the L763 panel.
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ulation [30,31]. Both residues are implicated in the activation
of the SH2 containing adapter protein Shc and the phospha-
tase SHP-2 (also known as PTPD1 or Syp). Tyrosine phos-
phorylation of either Shc and SHP-2 leads to the activation of
RAS and subsequently to transcriptional activation of the c-
fos gene [30,31]. The tyrosine motifs 612 (YLXL) and 750
(YXXL) exhibit a clear homology with sequences found in
other cytokine receptors which are involved in STAT5 activa-
tion [32], while the sequence of Tyr
695
(YVSS) lacks this ho-
mology. The ¢nding that each of these tyrosines was su¤cient
to mediate maximal STAT activity indicates that di¡erent
sequences within a receptor can serve as a binding site for
STAT5. These data show, together with the involvement of
Tyr
577
and Tyr
750
for Shc and SHP-2 activation, that distinct
sets of tyrosines are involved in di¡erent signaling routes. We
can also conclude that the activation of a speci¢c signaling
route can be controlled by multiple tyrosines, showing the
partial functional redundancy of these residues, as was also
described for STAT activation by the EPOR and GHR [25^
27]. Finally, the redundancy and speci¢city of the tyrosine
residues in the activation of di¡erent signal transduction
routes suggest that these pathways are involved in distinct
cellular functions. Although STAT5 is implicated to activate
speci¢c genes involved in proliferation and di¡erentiation of
hematopoietic cells, the precise function(s) of STAT proteins
in IL-5 signaling still remains to be elucidated.
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